Morgan Stanley Biotechnology

Morgan Stanley

$1.49 Trillion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
NBTX Nanobiotix S.A.	$258M	$25,000 0.0% of portfolio	5,300	Q2 2025 Reduced 13.11%
AIKI A Ikido Pharma Inc.	$20.8M	$22,000 0.0% of portfolio	6,000	Q2 2025 New
IGMS Igm Biosciences, Inc.	$37.7M	$22,000 0.0% of portfolio	20,100	Q2 2025 Reduced 41.75%
CUE Cue Biopharma, Inc.	$28M	$20,000 0.0% of portfolio	29,452	Q2 2025 Added 2.65%
STTK Shattuck Labs, Inc.	$32.2M	$19,000 0.0% of portfolio	24,088	Q2 2025 Reduced 70.03%
BYSI Beyond Spring Inc.	$78.2M	$19,000 0.0% of portfolio	8,210	Q1 2025 Added 3.79%
NERV Minerva Neurosciences, Inc.	$9.4M	$18,000 0.0% of portfolio	11,008	Q2 2025 Added 0.04%
VACC Vaccitech PLC	$127M	$16,000 0.0% of portfolio	4,852	Q2 2025 Added 457.06%
LVTX Lava Therapeutics Nv	$39.5M	$15,000 0.0% of portfolio	11,600	Q2 2025 Reduced 1.69%
ONCY Oncolytics Biotech Inc	$49.8M	$14,000 0.0% of portfolio	18,853	Q2 2025 Added 8.64%
RLYB Rallybio Corp	$16.1M	$12,000 0.0% of portfolio	36,484	Q3 2024 Reduced 33.77%
XTLB Xtl Biopharmaceuticals LTD	$7.52M	$12,000 0.0% of portfolio	11,011	Q2 2025 Reduced 16.9%
IPA Immuno Precise Antibodies Ltd.	$50.2M	$10,000 0.0% of portfolio	10,000	Q2 2025 Reduced 20.21%
CGTX Cognition Therapeutics Inc	$25M	$9,000 0.0% of portfolio	31,069	Q1 2025 Added 84.13%
PDSB Pds Biotechnology Corp	$35M	$9,000 0.0% of portfolio	7,434	Q2 2025 Reduced 57.07%
MAIA Maia Biotechnology, Inc.	$18.2M	$9,000 0.0% of portfolio	5,095	Q2 2024 Reduced 49.53%
IPSC Century Therapeutics, Inc.	$30.6M	$6,000 0.0% of portfolio	11,340	Q2 2025 Reduced 80.27%
ELEV Elevation Oncology, Inc.	$8.39M	$6,000 0.0% of portfolio	16,608	Q2 2025 Reduced 81.36%
IVA Inventiva S.A.	$155M	$6,000 0.0% of portfolio	2,098	Q2 2025 New
GNTA Genenta Science S.P.A.	$59.9M	$6,000 0.0% of portfolio	2,000	Q2 2025 Reduced 41.18%
DYAI Dyadic International Inc	$24.2M	$5,000 0.0% of portfolio	5,654	Q3 2024 Added 2,599.12%
CRTX Cortexyme, Inc.	$70.5M	$5,000 0.0% of portfolio	4,302	Q2 2025 Reduced 91.97%
SABSW Sab Biotherapeutics Inc Wt Exp	$0	$4,000 0.0% of portfolio	146,439	Q2 2024 Reduced 1.68%
OVID Ovid Therapeutics Inc.	$38.7M	$3,000 0.0% of portfolio	10,565	Q2 2025 Reduced 87.23%
RANI Rani Therapeutics Holdings, Inc.	$13M	$3,000 0.0% of portfolio	7,020	Q2 2025 Reduced 51.87%
AADI Aadi Bioscience, Inc.	$35.9M	$3,000 0.0% of portfolio	2,003	Q2 2025 Reduced 96.88%
CNTX Context Therapeutics Inc.	$10.9M	$2,000 0.0% of portfolio	3,500	Q2 2025 Added 3,400.0%
EQ Equillium, Inc.	$31.9M	$2,000 0.0% of portfolio	7,530	Q2 2025 Reduced 26.45%
PASG Passage Bio, Inc.	$306M	$2,000 0.0% of portfolio	6,529	Q2 2025 Reduced 4.39%
RVPH Reviva Pharmaceuticals Holdings, Inc.	$9.2M	$1,000 0.0% of portfolio	4,120	Q1 2025 Reduced 32.68%
ATHA Athira Pharma, Inc.	$14.4M	$1,000 0.0% of portfolio	5,112	Q1 2025 Reduced 14.97%
LTRN Lantern Pharma Inc.	$48.2M	$1,000 0.0% of portfolio	601	Q2 2024 Reduced 0.17%
MOLN Molecular Partners Ag	$114M	$1,000 0.0% of portfolio	367	Q3 2024 Added 36.24%
VOR Vor Biopharma Inc.	$63.2M	$0 0.0% of portfolio	503	Q2 2025 Reduced 98.58%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	383,616	Q2 2025 Reduced 13.31%
IMRN Immuron Limited	$11.8M	$0 0.0% of portfolio	-	Q2 2025 New
CNTB Connect Biopharma Holdings LTD	$125M	$0 0.0% of portfolio	100	Q2 2025 New
RPTX Repare Therapeutics Inc.	$65.4M	$0 0.0% of portfolio	513	Q2 2025 Added 52.23%
CLGN Coll Plant Biotechnologies LTD	$34.9M	$0 0.0% of portfolio	1	Q4 2023 Reduced 99.17%
PMCB Pharma Cyte Biotech, Inc.	$17.4M	$0 0.0% of portfolio	1	Q1 2025 Reduced 50.0%
RLMD Relmada Therapeutics, Inc.	$16.9M	$0 0.0% of portfolio	852	Q2 2025 Reduced 60.7%
ARMP Armata Pharmaceuticals, Inc.	$88.9M	$0 0.0% of portfolio	109	Q3 2024 Added 5,350.0%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.